您的位置: 首页 > 农业专利 > 详情页

RECOMBINANT ONCOLYTIC VIRUSES FOR CANCER THERAPY
专利权人:
UNIVERSITY HEALTH NETWORK;CHILDREN'S HOSPITAL OF EASTERN ONTARIO RESEARCH INSTITUTE INC.
发明人:
Judith Andrea MCCART,David Francis STOJDL,Tiffany Yun-Yee HO
申请号:
US16338263
公开号:
US20200046784A1
申请日:
2017.10.02
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The disclosure provides a recombinant oncolytic poxvirus including vaccinia virus comprising one or more inactivated immunomodulatory gene selected from NIL, K1L, K3L, A46R, and/or A52R, optionally further comprising inactivated TK and/or VGF genes. The disclosure also provides methods and for the use of these recombinant oncolytic poxvirus in oncolytic virotherapy. Also provided in the disclosure are vector constructs for generating recombinant oncolytic poxviruses including for example vaccinia viruses that have one or more inactivated immunomodulatory genes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充